Burrage Capital Management’s Verastem VSTM Stock Holding History

Burrage Capital Management’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-58,799	Closed	-$2.87M	–	17
2021 Q2	$2.87M	Buy	+58,799	New	+$2.45M	2.88%	15

Other funds holding VSTM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

Burrage Capital Management's VSTM Position: Q3 2021 in Review

Burrage Capital Management sold out of Verastem (VSTM) in Q3 2021, closing a stake of 58,799 shares — an estimated $2.87M sold.

Burrage Capital Management first reported a position in VSTM in Q2 2021 and held it in 1 quarter. The position peaked at $2.87M in Q2 2021. 147 funds tracked by Wall St. Rank hold VSTM as of Q3 2021.

Burrage Capital Management reported no remaining Verastem position as of Q3 2021 after selling out during the quarter.
Burrage Capital Management sold 58,799 Verastem shares in Q3 2021, an estimated $2.87M.
Burrage Capital Management first reported a position in Verastem in Q2 2021 and held it in 1 quarter.
Burrage Capital Management's Verastem position peaked at $2.87M in Q2 2021.
147 funds tracked by Wall St. Rank held Verastem as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.